Myocardial perfusion in hypertensive patients with normal coronary angiograms

Journal of Hypertension

Volumn 26, Issue 8, 2008, Pages 1686-1694

  Kawecka Jaszcz, Kalina ^a   Czarnecka, Danuta ^a   Olszanecka, Agnieszka ^a   Klecha, Artur ^a   Kwiecień Sobstel, Agnieszka ^a   Stolarz Skrzypek, Katarzyna ^a   Pennell, Dudley J ^b   Pasowicz, Mieczysław ^c   Klimeczek, Piotr ^c   Bany, Robert P ^c  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Cardiovascular magnetic resonance imaging; Coronary microcirculation; Hypertension; Left ventricular hypertrophy

Indexed keywords

ADENOSINE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; THORAX PAIN; AGED; ANGINA PECTORIS; BLOOD PRESSURE; CORONARY ARTERY BLOOD FLOW; HEART MUSCLE ISCHEMIA; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY;

ADULT; AGED; ANGINA PECTORIS; BLOOD PRESSURE; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 51549119602     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328303df42     Document Type: Article

References (40)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61. prospective studies. Lancet 2002; 360:1903-1913.
2. Kemp HG, Kronmal RA, Vlietstra RE, Frye RL. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS Registry study. J Am Coll Cardiol 1986; 7:479-483.
3. Cannon RO III. Epstein SE 'microvascular angina' as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988; 61:1338-1343.
4. Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 2004; 109:568-572.
5. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, et al., Society for Cardiovascular Magnetic Resonance; Working Group on Cardiovascular Magnetic Resonance of the European Society of Cardiology. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel Report. Eur Heart J 2004; 25:1940-1965.
6. Parkka JP, Niemi P, Saraste A, Koskenvuo JW, Komu M, Oikonen V, et al. Comparison of MRI and positron emission tomography for measuring myocardial perfusion reserve in healthy humans. Magn Reson Med 2006; 55:772-779.
7. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, Pennell DJ. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002; 346:1948-1953.
8. Lanza GA, Buffon A, Sestito A, Natale L, Sgueglia GA, Galiuto L, et al. Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. JAm Coll Cardiol 2008;51:466- 472.
9. Vermeltfoort IA, Bondarenko O, Raijmakers PG, Odekerken DA, Kuijper AF, Zwijnenburg A, et al. Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study. Eur Heart J 2007; 28:1554-1558.
10. 2003. European Society ofHypertension -European Society ofCardiology. Guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-1053.
11. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and right dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequence. J Magn Reson Imaging 2003; 17:323-329.
12. Schwitter J, DeMarco T, Kneifel S, von Schulthess GK, Jorg MC, Arheden H, et al. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography. Circulation 2000;101:2696-2702.
13. Koskenvuo JW, Sakuma H, Niemi P, Toikka JO, Knuuti J, Laine H, et al. Global myocardial blood flow reserve measurements by MRI and PET are comparable. J Magn Reson Imaging 2001; 13:361-366.
14. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003; 108:432-437.
15. Camici PG, Crea F. Coronary microcirculation dysfunction. N Engl J Med 2007; 356:830-840.
16. Kjaer A, Meyer C, Wachtell K, Olsen MH, Ibsen H, Opie L, et al. Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy. Am J Cardiol 2005; 96:1692-1698.
17. Kozakova M, Palombo C, Pratali L, Pittella G, Galetta F, L'Abbate A. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension 1997; 29:551-559.
18. Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR Jr, Lerman A. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 2000; 35:1654-1660.
19. Gimelli A, Schneider-Eicke J, Neglia D, Sambuceti G, Giorgetti A, Bigalli G, et al. Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy. JAm Coll Cardiol 1998; 31:366-373.
20. Marroquin OC, Holubkov R, Edmundowicz D, Rickens C, Pohost G, Buchthal S, et al. Heterogenity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: implications for clinical practice. Am Heart J 2003; 145:628-635.
21. Levy BI, Ambrosio G, Preis AR, Struijker-Boudier HAJ. Microcirculation in hypertension. A new target for treatment? Circulation 2001; 104:735-740.
22. Chilian WM. Coronary microcirculation in health and disease. Summary of an NHLBI workshop. Circulation 1997; 95:522-528.
23. Li XY, Li R, Yu W, Shi HY, Wei LX. Differences in coronary microvascular lesions in coronary heart disease and hypertension: an autopsy study of elderly patients. Chin Med J 2004; 111:207-212.
24. Perticone F, Ceravolo R, Pujia A, Ventura G, lacopino S, Scozzafava A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104:191-196.
25. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106:653-658.
26. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997; 96:3390-3395.
27. Wang J, Whitt SP, Rubin LJ, Huxley VH. Differential coronary microvascular exchange responses to adenosine: roles of receptor and microvessel subtypes. Microcirculation 2005; 12:313-326.
28. Sato A, Terata K, Miura H, Toyama K, Loberiza FR Jr, Hatoum OA, et al. Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. Am J Physiol Heart Circ Physiol 2005; 288:1633-1640.
29. Palmieri V, Storto G, Arezzi E, Pellegrino T, Mancini M, Di Minno G, et al. Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects. J Hum Hypertens 2005; 19:941-950.
30. Berttcher M, Botker HE, Sonne H, Nielsen TT, Czernin J. Endothelium dependent and -independent perfusion reserve and the effect ofl-arginine on myocardial perfusion in patients with syndrome X. Circulation 1999;99:1795-1801.
31. Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, et al., National Institutes of Health-National Heart, Lung, and Blood Institute. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109:2993-2999.
32. Britten MB, Zeiher AM, Schachinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis 2004;15:259- 264.
33. Palombo C, Kozakova M, Magagna A, Bigalli G, Morizzo C, Ghiadoni L, et al. Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients. J Hypertens 2000;18:453-459.
34. Levy BI, Duriez M, Samuel JL. Coronary microvasculature alteration in hypertensive rats: effect oftreatment with diuretic and an ACE inhibitor. Am J Hypertens 2001; 14:7-13.
35. Schwartzkopff B, Brehm M, Mundhenke M, Strauer BE. Repair ofcoronary arerioles after treatment with perindopril in hypertensive heart disease. Hypertension 2000; 36:220-225.
36. Rakusan K, Cicutti N, Kazda S, Turek Z. Effect of nifedipine on coronary capillary geometry in normotensive and hypertensive rats. Hypertension 1994; 24:205-211.
37. Dalhof B, Hansson L. The influence of antihypertensive therapy on the structural changes in essential hypertension: different effects of enalapril and hydrochrorothiazide. J Intern Med 1993; 234:271-279.
38. Chillion JC, Baumbach GL. Effects of an angiotensin-converting enzyme inhibitor and beta blocker on cerebral arterioles in rats. Hypertension 1999;33:856-861.
39. Buus NH, Boøttcher M, Joørgensen CG, Christensen KL, Thygesen K, Nielsen TT, Mulvany MJ. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension. Hypertension 2004; 44:465-470.
40. Boøttcher M, Czernin J, Sun K, Phelps ME, Schelbert HR. Effect of beta 1. adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med 1997; 38:442-446.